C4 Therapeutics, Inc. (CCCC) NASDAQ

1.51

+0.08(+5.59%)

Updated at July 01 04:00PM

Currency In USD

Valuation

Market Cap249.73M
Enterprise Value259.99M
P/E Ratio-1.04
PEG Ratio-0.39
Price/Sales Ratio2.7
Price/Book Ratio0.55
Enterprise/Revenue3.02
Enterprise/EBITDA-1.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-2.6
Operating Margin-2.93

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.46

Income Statement

Revenue35.58M
Revenue/Share0.56
Gross Profit35.58M
EBITDA-103.37M
Net Income-105.32M
Diluted EPS-1.52

Balance Sheet

Total Cash215.09M
Total Cash/Share3.04
Total Debt64.37M
Total Debt/Equity0.33
Current Ratio5.7
Book Value Per Share2.75

Price History

52-Week Change-68.87
52-Week High7.66
52-Week Low1.09
Moving Average 50 Days1.49
Moving Average 200 Days3.37

Statistics

Average Volume1.22M
Shares Outstanding71.01M
% Held by Institutions92.4

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A